The latest news, announcements and press releases from Brainlab.
Brainlab and Precision NeuroMed have a new strategic partnership for an artificial intelligence (AI)-enabled treatment planning platform. Once developed and commercialized, this platform will facilitate convection enhanced delivery (CED) to the brain.
There are long-standing limitations in this area of medicine, the companies say, due to the blood-brain barrier. For the most part, systemically administered drugs usually cannot reach therapeutic concentrations in the brain.
This is the News section of the company profile page for Brainlab on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
